Compounds > n-methyl-n-formylhydrazine
Page last updated: 2024-11-05

n-methyl-n-formylhydrazine

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth Market Indicators

Description

N-methyl-N-formylhydrazine: structure [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]

Cross-References

ID SourceID
PubMed CID12962
MeSH IDM0066675

Synonyms (36)

Synonym
unii-3l13r06h7d
3l13r06h7d ,
hydrazine, 1-formyl-1-methyl-
nsc122452
nsc-122452
1-methylformylhydrazine
formic acid, 1-methylhydrazide
758-17-8
methylformylhydrazine
1-methyl-1-formylhydrazide
n-formyl-n-methylhydrazine
formic acid, methylhydrazide
2-methyl-2-formylhydrazine
hydrazinecarboxaldehyde, 1-methyl-
n-methyl-n-formylhydrazine
n-methylformic hydrazide
hsdb 3510
nsc 122452
brn 2036827
MFH ,
1-methyl-1-formylhydrazine
ccris 1182
n-amino-n-methylformamide
AKOS006279317
n-methyl-n-formylhydrazine [hsdb]
1-formyl-1-methylhydrazine
1-methylhydrazinecarboxaldehyde
CCG-214845
RSFOTOSOKJMMCB-UHFFFAOYSA-N
DTXSID2020840
CS-0084846
n-methylformohydrazide
D74578
Q27257474
SY338851
mfcd01726298
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Research

Studies (9)

TimeframeStudies, This Drug (%)All Drugs %
pre-19908 (88.89)18.7374
1990's1 (11.11)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Market Indicators

Research Demand Index: 11.79

According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be weak demand-to-supply ratio for research on this compound.

MetricThis Compound (vs All)
Research Demand Index11.79 (24.57)
Research Supply Index2.48 (2.92)
Research Growth Index4.28 (4.65)
Search Engine Demand Index0.00 (26.88)
Search Engine Supply Index0.00 (0.95)

This Compound (11.79)

All Compounds (24.57)

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials0 (0.00%)5.53%
Reviews0 (0.00%)6.00%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Other11 (100.00%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]
SubstanceRelationship StrengthStudiesTrialsClassesRoles
acetaldehyde
Acetaldehyde: A colorless, flammable liquid used in the manufacture of acetic acid, perfumes, and flavors. It is also an intermediate in the metabolism of alcohol. It has a general narcotic action and also causes irritation of mucous membranes. Large doses may cause death from respiratory paralysis.. acetaldehyde : The aldehyde formed from acetic acid by reduction of the carboxy group. It is the most abundant carcinogen in tobacco smoke.. aldehyde : A compound RC(=O)H, in which a carbonyl group is bonded to one hydrogen atom and to one R group.. acetyl group : A group, formally derived from acetic acid by dehydroxylation, which is fundamental to the biochemistry of all forms of life. When bound to coenzyme A, it is central to the metabolism of carbohydrates and fats.		2.3720aldehydecarcinogenic agent;
EC 3.5.1.4 (amidase) inhibitor;
electron acceptor;
Escherichia coli metabolite;
human metabolite;
mouse metabolite;
mutagen;
oxidising agent;
Saccharomyces cerevisiae metabolite;
teratogenic agent
formaldehyde
paraform: polymerized formaldehyde; RN given refers to parent cpd; used in root canal therapy		1.9710aldehyde;
one-carbon compound		allergen;
carcinogenic agent;
disinfectant;
EC 3.5.1.4 (amidase) inhibitor;
environmental contaminant;
Escherichia coli metabolite;
mouse metabolite;
Saccharomyces cerevisiae metabolite
hexobarbital
Hexobarbital: A barbiturate that is effective as a hypnotic and sedative.. hexobarbital : A member of the class of barbiturates taht is barbituric acid substituted at N-1 by methyl and at C-5 by methyl and cyclohex-1-enyl groups.		1.9510barbiturates
aminopyrine
Aminopyrine: A pyrazolone with analgesic, anti-inflammatory, and antipyretic properties but has risk of AGRANULOCYTOSIS. A breath test with 13C-labeled aminopyrine has been used as a non-invasive measure of CYTOCHROME P-450 metabolic activity in LIVER FUNCTION TESTS.. aminophenazone : A pyrazolone that is 1,2-dihydro-3H-pyrazol-3-one substituted by a dimethylamino group at position 4, methyl groups at positions 1 and 5 and a phenyl group at position 2. It exhibits analgesic, anti-inflammatory, and antipyretic properties.		1.9510pyrazolone;
tertiary amino compound		antipyretic;
environmental contaminant;
non-narcotic analgesic;
non-steroidal anti-inflammatory drug;
xenobiotic
monomethylhydrazine
Monomethylhydrazine: Hydrazine substituted by one methyl group.		3.5790
diazene
[no description available]		1.9710nitrogen hydride
gyromitrin
gyromitrin: isolated from edible mushroom Gyromitra (Helvella) esculenta; inhalation hallucinogen; highly toxic; structure		1.9510
ConditionIndicatedRelationship StrengthStudiesTrials
Cancer of Lung
[description not available]		03.0550
Experimental Neoplasms
[description not available]		03.0550
Lung Neoplasms
Tumors or cancer of the LUNG.		03.0550
Cancer of Gallbladder
[description not available]		02.8740
Cancer of Liver
[description not available]		02.6530
Gallbladder Neoplasms
Tumors or cancer of the gallbladder.		02.8740
Liver Neoplasms
Tumors or cancer of the LIVER.		02.6530
Adenocarcinoma, Basal Cell
[description not available]		01.9610
Adenoma, Basal Cell
[description not available]		01.9610
Benign Neoplasms
[description not available]		01.9610
Adenocarcinoma
A malignant epithelial tumor with a glandular organization.		01.9610
Adenoma
A benign epithelial tumor with a glandular organization.		01.9610
Neoplasms
New abnormal growth of tissue. Malignant neoplasms show a greater degree of anaplasia and have the properties of invasion and metastasis, compared to benign neoplasms.		01.9610
Bile Duct Cancer
[description not available]		02.3620
Experimental Hepatoma
[description not available]		01.9510
Angioma, Sclerosing
[description not available]		01.9510
Bile Duct Neoplasms
Tumors or cancer of the BILE DUCTS.		02.3620
Histiocytoma, Benign Fibrous
A benign tumor composed, wholly or in part, of cells with the morphologic characteristics of HISTIOCYTES and with various fibroblastic components. Fibrous histiocytomas can occur anywhere in the body. When they occur in the skin, they are called dermatofibromas or sclerosing hemangiomas. (From DeVita Jr et al., Cancer: Principles & Practice of Oncology, 5th ed, p1747)		01.9510
Acute Liver Injury, Drug-Induced
[description not available]		01.9510
Mushroom Poisoning
Poisoning from ingestion of mushrooms, primarily from, but not restricted to, toxic varieties.		02.3620
Chemical and Drug Induced Liver Injury
A spectrum of clinical liver diseases ranging from mild biochemical abnormalities to ACUTE LIVER FAILURE, caused by drugs, drug metabolites, herbal and dietary supplements and chemicals from the environment.		01.9510
Angioma
A vascular anomaly due to proliferation of blood or lymphatic vessels that forms a tumor-like mass. Vessels in the angioma may or may not be dilated.		01.9510
Angiosarcoma
[description not available]		01.9510
Hemangioma
A vascular anomaly due to proliferation of BLOOD VESSELS that forms a tumor-like mass. The common types involve CAPILLARIES and VEINS. It can occur anywhere in the body but is most frequently noticed in the SKIN and SUBCUTANEOUS TISSUE. (from Stedman, 27th ed, 2000)		01.9510
Hemangiosarcoma
A rare malignant neoplasm characterized by rapidly proliferating, extensively infiltrating, anaplastic cells derived from blood vessels and lining irregular blood-filled or lumpy spaces. (Stedman, 25th ed)		01.9510